FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
Authors
Keywords
-
Journal
eLife
Volume 4, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2015-09-29
DOI
10.7554/elife.09811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
- (2015) Phillip B. Murray et al. Science Signaling
- Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
- (2015) Phillip B. Murray et al. Science Signaling
- Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome
- (2014) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma
- (2014) G. Umapathy et al. Science Signaling
- The Neuroblastoma ALK(I1250T) Mutation Is a Kinase-Dead RTK In Vitro and In Vivo
- (2014) Christina Schönherr et al. Translational Oncology
- Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
- (2012) D. Chand et al. Disease Models & Mechanisms
- Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase: Functions and genetic interactions in learning, memory and adult neurogenesis
- (2011) Joseph B. Weiss et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy
- (2010) T. Martinsson et al. CANCER RESEARCH
- Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells
- (2010) C Schönherr et al. ONCOGENE
- ALK Mutants in the Kinase Domain Exhibit Altered Kinase Activity and Differential Sensitivity to Small Molecule ALK Inhibitors†̈
- (2009) Lihui Lu et al. BIOCHEMISTRY
- High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours
- (2008) Helena Carén et al. BIOCHEMICAL JOURNAL
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started